Time to bet on genomics?
For Print Only Logo
Insights and Market Perspectives

Time to bet on genomics?

Author: Carmen Tang

November 12, 2018

Advancements in biotechnology, genome sequencing and gene editing have given rise to whole new areas in health care—and created new opportunities for investors. Carmen Tang explains.

Can’t view the video?  Click here to view in your browser.

About AGF Management Limited

Founded in 1957, AGF Management Limited (AGF) is an independent and globally diverse asset management firm. AGF brings a disciplined approach to delivering excellence in investment management through its fundamental, quantitative, alternative and high-net-worth businesses focused on providing an exceptional client experience. AGF’s suite of investment solutions extends globally to a wide range of clients, from financial advisors and individual investors to institutional investors including pension plans, corporate plans, sovereign wealth funds and endowments and foundations.

For further information, please visit AGF.com.

© 2018 AGF Management Limited. All rights reserved.

Written by

Carmen Tang

Carmen Tang, MSc., MBA, CFA

Equity Analyst

AGF Investments Inc.

More articles like this.

2019 Outlook: The Year Ahead – Part one

2019 Outlook: The Year Ahead – Part one

Is a recession imminent? AGF’s CEO and Chief Investment Officer Kevin McCreadie explains it’s an unlikely…

Read More
The Big Picture: A history of market corrections

The Big Picture: A history of market corrections

Historically, figures show that 75% of market corrections of more than 10% do not lead to bear markets.

Read More
ESG integration a top priority of investors

ESG integration a top priority of investors

Today, there’s never been more evidence that ESG integration is seen as a path to creating long-term value for shareholders while also contributing to a better environment, healthier communities and good corporate governance practices.

Read More